DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/j2dxhz/global_acute) has announced the addition of the "Global Acute Ischemic Stroke Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its Acute Ischemic Stroke patient population study in a new report Global Acute Ischemic Stroke Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Acute Ischemic Stroke epidemiology, Acute Ischemic Stroke diagnosed patients, and Acute Ischemic Stroke treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Acute Ischemic Stroke derived from epidemiological analysis, percentage of patients diagnosed with Acute Ischemic Stroke, and percentage of patients treated with Acute Ischemic Stroke therapy.
This study helps executives estimate Acute Ischemic Stroke market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
This report provides estimates and forecasts of Acute Ischemic Stroke prevalence, Acute Ischemic Stroke diagnosis rate, and Acute Ischemic Stroke treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Acute Ischemic Stroke: Disease Definition
- Acute Ischemic Stroke Patient Flow
- Acute Ischemic Stroke Prevalence
- Acute Ischemic Stroke Diagnosed Patients
Go here to see the original:
Research and Markets: Global Acute Ischemic Stroke Epidemiology and Patient Flow Analysis - 2012